Colossal, the biotech startup working on de-extincting the woolly mammoth and the dodo, thinks it can make trillions of dollars — almost none of it from consumer-facing products. Liz and Rohan dive into it all with CEO Ben Lamm, who has already spun out four businesses as he’s built the bioscience business with a focus on serving governments and nations looking to build drought-resistant plants, plastic-munching microbes, and much more (some of it classified!) This season of Compound Interest is in partnership with Amazon Business. Amazon Business is a trusted partner that transforms business buying by combining Amazon's vast selection, competitive pricing, and fast delivery with added tools and insights to help businesses simplify purchasing, manage spend, and buy smarter.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Mark Cuban on his pharma fight, Dallas Mavs regrets, and the PE-ification of sports
America’s best energy trader on fixing higher ed and the dangers of prediction markets
Why Oura’s CEO is embracing Washington regulation
Can tiny homes — and tiny-home mortgages — solve the housing crisis?
Free AI-powered recaps of Compound Interest from Semafor Business and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.